Table 1.
Baseline Characteristics of the Study Population
| Characteristic | ARMD Group n = 273 |
Non-ARMD Group n = 226 |
Control Group n = 560 |
|---|---|---|---|
| Age, years | 62.1 (10.8) | 59.6 (11.1)* | 61.22 (7.82)† |
|
| |||
| Men, n (%) | 207 (75.8) | 184 (81.4) | 450 (80.4) |
|
| |||
| Recurrent myocardial infarction or angina, n (%) | 97 (36.9) | 57 (26.1)* | … |
|
| |||
| One-vessel disease | 97 (39.1) | 101 (47.2) | … |
| Two-vessel disease | 80 (32.3) | 61 (28.5) | |
| Three-vessel disease | 71 (28.6) | 52 (24.3) | |
|
| |||
| Educational level, n (%) | |||
| Lower than higher | 103 (51.5) | 105 (63.3) | |
| Higher | 97 (48.5) | 78 (46.7) | … |
|
| |||
| History of drug treatment, n (%) | |||
| Calcium channel blocker | 19 (7.0) | 22 (9.7) | |
| Statin | 18 (6.6) | 15 (6.6) | … |
| Beta-blocker | 66 (24.2) | 49 (21.7) | |
| ACE | 66 (24.2) | 47 (20.8) | |
| Diuretic | 10 (3.7) | 9 (4.0) | |
| Antiplatelet (aspirin/clopidogrel) | 50 (18.3) | 42 (18.6) | |
|
| |||
| Systolic blood pressure, mm Hg | 144.1 (21.9) | 143.5 (21.1) | … |
|
| |||
| Diastolic blood pressure, mm Hg | 86.9 (11.4) | 87.8 (12.1) | … |
|
| |||
| Body mass index, kg/m2 | 28.8 (4.8) | 28.1 (4.4) | 28.41 (4.9) |
|
| |||
| White blood cell count, ×109/L | 9.24 (3.5) | 9.5 (3.0) | … |
|
| |||
| Neutrophil count, ×109/L | 7.1 (2.8) | 8.0 (2.6) | … |
|
| |||
| Monocyte count, ×109/L | 0.7 (0.4) | 0.8 (0.8) | … |
|
| |||
| Lymphocyte count, ×109/L | 1.8 (0.8) | 1.9 (0.9) | … |
|
| |||
| Platelet count, ×109/L | 234.1 (52.2) | 261.5 (92.3) | … |
Values are mean (standard deviation) unless otherwise stated. Ellipses indicate no data available.
ACE, angiotensin-converting enzyme; ARMD, age-related macular degeneration.
*
P<0.05 between non-ARMD and ARMD groups;
†
P<0.05 between patients with ARMD or without ARMD taken together and control group.